Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron in Overactive Bladder
NCT01043666Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of mirabegron in overactive bladder (OAB), sponsored by Astellas Pharma. Started Dec 2009; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01043666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01043666.